[Clinical results with cephalexin (Syncl "Toyo") for bacterial pneumonia (author's transl)]. 1974

F Yamasaku, and S Aoki, and G Seki, and B Ito, and T Kainuma

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011014 Pneumonia Infection of the lung often accompanied by inflammation. Experimental Lung Inflammation,Lobar Pneumonia,Lung Inflammation,Pneumonia, Lobar,Pneumonitis,Pulmonary Inflammation,Experimental Lung Inflammations,Inflammation, Experimental Lung,Inflammation, Lung,Inflammation, Pulmonary,Inflammations, Lung,Inflammations, Pulmonary,Lobar Pneumonias,Lung Inflammation, Experimental,Lung Inflammations,Lung Inflammations, Experimental,Pneumonias,Pneumonias, Lobar,Pneumonitides,Pulmonary Inflammations
D011023 Pneumonia, Staphylococcal Pneumonia caused by infections with bacteria of the genus STAPHYLOCOCCUS, usually with STAPHYLOCOCCUS AUREUS. Staphylococcal Pneumonia,Staphylococcus Aureus Pneumonia,Pneumonia, Staphylococcus Aureus,Pneumonias, Staphylococcal,Pneumonias, Staphylococcus Aureus,Staphylococcal Pneumonias,Staphylococcus Aureus Pneumonias
D001996 Bronchopneumonia Inflammation of the lung parenchyma that is associated with BRONCHITIS, usually involving lobular areas from TERMINAL BRONCHIOLES to the PULMONARY ALVEOLI. The affected areas become filled with exudate that forms consolidated patches. Bronchial Pneumonia,Bronchial Pneumonias,Bronchopneumonias,Pneumonia, Bronchial,Pneumonias, Bronchial
D002506 Cephalexin A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms. 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))-,Cefalexin,Cephalexin Dihydride,Cephalexin Hemihydrate,Cephalexin Hydrochloride,Cephalexin Monohydrate,Cephalexin Monohydrochloride,Cephalexin Monohydrochloride, Monohydrate,Cephalexin, (6R-(6alpha,7alpha(R*)))-Isomer,Cephalexin, (6R-(6alpha,7beta(S*)))-Isomer,Cephalexin, (6R-(6alpha,7beta))-Isomer,Cephalexin, Monosodium Salt,Cephalexin, Monosodium Salt, (6R-(6alpha,7beta))-Isomer,Ceporexine,Palitrex
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations

Related Publications

F Yamasaku, and S Aoki, and G Seki, and B Ito, and T Kainuma
November 1977, The Japanese journal of antibiotics,
F Yamasaku, and S Aoki, and G Seki, and B Ito, and T Kainuma
August 1977, The Japanese journal of antibiotics,
F Yamasaku, and S Aoki, and G Seki, and B Ito, and T Kainuma
January 1975, Praxis der Pneumologie,
F Yamasaku, and S Aoki, and G Seki, and B Ito, and T Kainuma
November 1977, The Japanese journal of antibiotics,
F Yamasaku, and S Aoki, and G Seki, and B Ito, and T Kainuma
February 1978, The Japanese journal of antibiotics,
F Yamasaku, and S Aoki, and G Seki, and B Ito, and T Kainuma
January 1978, Padiatrie und Padologie,
F Yamasaku, and S Aoki, and G Seki, and B Ito, and T Kainuma
January 1979, Arzneimittel-Forschung,
F Yamasaku, and S Aoki, and G Seki, and B Ito, and T Kainuma
January 1979, Arzneimittel-Forschung,
F Yamasaku, and S Aoki, and G Seki, and B Ito, and T Kainuma
April 1982, Casopis lekaru ceskych,
F Yamasaku, and S Aoki, and G Seki, and B Ito, and T Kainuma
February 1979, Wiener medizinische Wochenschrift (1946),
Copied contents to your clipboard!